MINI REVIEW
Published on 26 Aug 2025
Research advances in immune agonists and their nanoparticles for enhancing the immunotherapeutic efficacy of PD-1 inhibitors in malignancies
doi 10.3389/fonc.2025.1618903
- 515 views
- Frontiers in Bioengineering and Biotechnology
- Nanobiotechnology
- Research Topics
- Nanotechnology-Based Delivery Systems for Cancer Treatment
Nanotechnology-Based Delivery Systems for Cancer Treatment
2,491
Total downloads
12k
Total views and downloads
Articles
REVIEW
Published on 08 Aug 2025
Opportunities, obstacles and challenges of nano-immunotherapy in melanoma
doi 10.3389/fimmu.2025.1611423
- 692 views
MINI REVIEW
Published on 22 Jul 2025
Reprogramming the tumor-immune landscape via nanomaterial-induced immunogenic cell death: a mini review
doi 10.3389/fbioe.2025.1635747
- 1,078 views
SYSTEMATIC REVIEW
Published on 08 Jul 2025
Hydrogels in cancer treatment: mapping the future of precision drug delivery
doi 10.3389/fimmu.2025.1607240
- 2,051 views
ORIGINAL RESEARCH
Published on 18 Jun 2025
Mesoporous silica nanoparticles loaded Au nanodots: a self-amplifying immunotherapeutic depot for photothermal immunotherapy
doi 10.3389/fimmu.2025.1616539
- 605 views
ORIGINAL RESEARCH
Published on 11 Feb 2025
Manganese-pyrochloric acid photosensitizer nanocomplexes against osteosarcoma: achieving both high activatability and high effectiveness
doi 10.3389/fbioe.2024.1485549
- 1,218 views
ORIGINAL RESEARCH
Published on 22 Jan 2025
DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells
doi 10.3389/fimmu.2024.1509322
- 1,842 views
ORIGINAL RESEARCH
Published on 08 Jan 2025
Loading monocytes with magnetic nanoparticles enables their magnetic control without toxicity
doi 10.3389/fbioe.2024.1498120
- 1,079 views
- 1 citation
Published in
Frontiers in Bioengineering and Biotechnology
Nanobiotechnology
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore
Frontiers in Molecular Biosciences
- 4.0 impact factor
- 8.8 citescore
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore